STRs in panel
Prev Next

Autism

Gene: CTNND2

Green List (high evidence)

CTNND2 (catenin delta 2)
EnsemblGeneIds (GRCh38): ENSG00000169862
EnsemblGeneIds (GRCh37): ENSG00000169862
OMIM: 604275, ClinGen, DECIPHER
CTNND2 is in 3 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

PMID 41502569 (preprint) reports phenotypic and molecular information for 57 individuals, 42 previously unpublished, with heterozygous CTNND2 variants. The 41 CTNND2 variants included 12 previously reported loss-of-function- and one missense variant, and 28 novel variants comprising 10 missense and 18 predicted loss-of-function changes. Eight of the novel variants occurred de novo, and 12 were inherited from a parent with a neurodevelopmental phenotype. The most common clinical features were developmental delay (90%), intellectual disability (74%), and behavioral abnormalities (79%). Functional studies revealed impaired early neurogenesis in one patient-derived line, characterized by aberrant neural rosette formation. Transcriptome analysis showed dysregulated WNT signaling, and partial rescue of these defects was achieved by modulating the WNT pathway, highlighting δ-catenin's role in early neural development.

Note several of the reported missense variants in this gene have high gnomAD counts so these should be interpreted with caution. Nevertheless, large number of individuals reported now with LoF variants and NDD phenotype.
Created: 6 Feb 2026, 5:05 p.m. | Last Modified: 6 Feb 2026, 5:05 p.m.
Panel Version: 0.243
Two individuals with intragenic deletions. One family with missense variant and epilepsy. Association with autism in a large cohort and zebrafish model.
Created: 17 Jan 2020, 4:43 p.m. | Last Modified: 17 Jan 2020, 4:43 p.m.
Panel Version: 0.38

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Neurodevelopmental disorder, MONDO:0700092, CTNND2-related

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
Phenotypes
  • Intellectual disability
  • Autism
  • Epilepsy
OMIM
604275
ClinGen
CTNND2
DECIPHER
CTNND2
Clinvar variants
Variants in CTNND2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

6 Feb 2026, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: ctnnd2 has been classified as Green List (High Evidence).

17 Jan 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: ctnnd2 has been classified as Amber List (Moderate Evidence).

17 Jan 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: ctnnd2 has been classified as Amber List (Moderate Evidence).

17 Jan 2020, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: CTNND2 were changed from to Intellectual disability; Autism; Epilepsy

17 Jan 2020, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: CTNND2 were set to

17 Jan 2020, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: CTNND2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: CTNND2 was added gene: CTNND2 was added to Autism_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: CTNND2 was set to Unknown